Dina Fine Maron, Editor of Health & Medicine at Scientific American, joins Cheddar to discuss some of the biggest changes to science regulations we'll see in 2018. From food labels to nonaddictive cigarettes, people need to be aware of what might affect their everyday lives.
A revamped nutrition label was slated to debut in July of 2018, however the Trump administration is giving companies a longer window. Major companies now have until 2020 and smaller companies have until 2021. The new labels will have more detail on added sugar and calorie count. However, critics say the delay could be a major blow to the public's health.
Plus, the U.S. Food and Drug Administration aims to create a nonaddictive cigarette with lower nicotine levels. It hopes this will help smokers quit. However, the agency opened up the conversation to the public for input which will ellicit some strong views from the tobacco industry.
Verizon Media launches 'Yahoo Life,' a website dedicated to provided well-being services. CEO Guru Gowrappan talked to Cheddar about helping provide support for Verizon's employees and customers along with society at large.
Garret Reisman talks difficulty of returning to Earth from space as Nasa and SpaceX prepare for a return mission.
Transportation Workers Union Local 100 and the NYU School of Global Public Health are conducting a comprehensive study about why the pandemic hit the workers of New York City's transit system so hard early in the outbreak.
From Wall Street to Silicon Valley, these are the top stories that moved markets and had investors, business leaders, and entrepreneurs talking this week on Cheddar.
Dr. Anthony Fauci has told lawmakers that once a coronavirus vaccine is approved as safe and effective, Americans should have widespread access within a reasonable time.
New York City has over 6,000 high rise buildings and for the last 75 years most of the skyscrapers built were constructed with glass facades. This trend has continued in cities across the world like London, Moscow, and Shanghai. But over the years, the drawbacks have become more prominent. They may look like elegant symbols of modernity, but beyond that shimmer is a list of problems that has some leaders proposing bans. All that beauty comes at a price.
Volunteers rolled up their sleeves Monday to take part in the biggest test yet of an experimental COVID-19 vaccine.
From Wall Street to Silicon Valley, these are the top stories that moved markets and had investors, business leaders, and entrepreneurs talking this week on Cheddar.
Amgen Foundation is doubling down on its support for virtual education platform Khan Academy with a $3 million grant.
Sorrento Therapeutics has been approved by the FDA to move forward with Phase 2 trials of its 'Abivertinib' study. ICU patients in some SoCal hospitals will undergo testing of the orally administered drug.
